Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06919172 · ClinicalTrials.gov registry record · NA

iTBS/fMRI Study of Apex Control

A NA study of Transcranial Magnetic Stimulation, sponsored by Florida State University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
2
Study locations

NCT06919172 is a NA study of Transcranial Magnetic Stimulation that is actively recruiting participants, run by Florida State University. The registered enrollment target is 40 participants, above the 36-participant average among 7 other Transcranial Magnetic Stimulation trials with a reported enrollment target (11% higher). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06919172, a NA study of Transcranial Magnetic Stimulation, is actively recruiting participants, sponsored by Florida State University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

The objective of this study is to examine the effect of transcranial magnetic stimulation (TMS) on the prefrontal cortex and posterior parietal cortex.

Interventions

  • DEVICE transcranial magnetic stimulation

Study Locations (2)

Florida

  • Florida State University Psychology Department Building - Tallahassee
  • FSU MRI Facility - Tallahassee

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-01-06
Est. Completion 2026-11-30
Phase NA

Sponsor

Florida State University

219 total trials

What the Registry Record Tells You About NCT06919172

The ClinicalTrials.gov registry entry for NCT06919172 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 36-participant average among 7 other Transcranial Magnetic Stimulation trials with a reported enrollment target (11% higher). The listed sponsor is Florida State University, which has 219 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Transcranial Magnetic Stimulation appearing as the primary indexed condition, and to 1 intervention - of which transcranial magnetic stimulation is the first listed.

NCT06919172 reports 2 study locations spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06919172 about?

NCT06919172 is a clinical study titled "iTBS/fMRI Study of Apex Control". The objective of this study is to examine the effect of transcranial magnetic stimulation (TMS) on the prefrontal cortex and posterior parietal cortex.

What is the current status of trial NCT06919172?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-01-06. Estimated completion is 2026-11-30.

What conditions does trial NCT06919172 study?

This clinical trial studies the following conditions: Transcranial Magnetic Stimulation.

What interventions are being tested in trial NCT06919172?

The interventions under investigation include: transcranial magnetic stimulation (DEVICE).

Who is sponsoring clinical trial NCT06919172?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06919172 being conducted?

This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Transcranial Magnetic Stimulation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.